As of my last update in October 2023, specific information about the chemical substance TRK-IN-26 with the CAS number 2412309-52-3 is limited in publicly available databases. Generally, substances with such identifiers are often in the research phase, potentially serving as experimental compounds in pharmaceutical or biochemical studies. Characteristics of such compounds typically include their molecular structure, functional groups, solubility, stability, and biological activity, which are crucial for understanding their potential applications. Researchers may investigate these properties through various analytical techniques, including spectroscopy and chromatography, to determine their efficacy and safety profiles. If TRK-IN-26 is a novel compound, detailed information may be found in scientific literature or patent filings as it progresses through research and development stages. For the most accurate and up-to-date information, consulting specialized databases or recent publications in the field of medicinal chemistry would be advisable.

TRK-IN-26

2412309-52-3: As of my last update in October 2023, specific information about the chemical substance TRK-IN-26 with the CAS number 2412309-52-3 is limited in publicly available databases. Generally, substances with such identifiers are often in the research phase, potentially serving as experimental compounds in pharmaceutical or biochemical studies. Characteristics of such compounds typically include their molecular structure, functional groups, solubility, stability, and biological activity, which are crucial for understanding their potential applications. Researchers may investigate these properties through various analytical techniques, including spectroscopy and chromatography, to determine their efficacy and safety profiles. If TRK-IN-26 is a novel compound, detailed information may be found in scientific literature or patent filings as it progresses through research and development stages. For the most accurate and up-to-date information, consulting specialized databases or recent publications in the field of medicinal chemistry would be advisable.

<p>TRK-IN-26 (compound 12), a TRK inhibitor, holds potential for use in cancer research [1].</p>

CAS 2412309-52-3

TRK-IN-26

TRK-IN-26

Ref: TM-T87569